55.99160 USD
0.6197
1.09%
Last update Dec 16, 4:24 PM GMT
Market closed
Day range
55.5
57.69000
Previous close
56.61130
Open
55.5
Access this stock data via API
Subscribe
Crispr Therapeutics AG
55.99
0.62
1.09%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date 2021 2020 2019
Total reported revenue 0 0 0
Cost of revenue 2.3K 3.0K 4.0K
Gross profit -2.3K -3.0K -4.0K
Operating expense
Research & development
Selling general and admin 4.2M 2.6M 6.8M
Other operating expenses 550.0K 301.9K 1.8M
Operating income -4.7M -2.9M -8.6M
Non operating interest income
Income
Expense 190.8K 527.4K 376.3K
Other income expense -4.5M -2.5M -8.9M
Pretax income -9.4M -5.9M -17.9M
Tax provision
Net income -9.4M -5.9M -17.9M
Basic EPS -0.1 0.0 -0.1
Diluted EPS -0.1 0.0 -0.1
Basic average shares 207.3M 152.6M 133.0M
Diluted average shares 207.3M 152.6M 133.0M
EBITDA -6.1M -3.1M -8.6M
Net income from continuing op. -9.4M -5.9M -17.9M
Minority interests 0 538.8K 335.2K
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 24 minutes

03:50
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).